Cargando…

Cellular immunotherapy as a beacon of hope for hematological malignancies

Detalles Bibliográficos
Autores principales:	Lee, Hyun-Ju, Kim, Sang-Ki, Cho, Duck, Lee, Je-Jung
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Society of Hematology; Korean Society of Blood and Marrow Transplantation; Korean Society of Pediatric Hematology-Oncology; Korean Society on Thrombosis and Hemostasis 2015
Materias:	Perspective
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4595575/ https://www.ncbi.nlm.nih.gov/pubmed/26457276 http://dx.doi.org/10.5045/br.2015.50.3.126

Ejemplares similares

Immune-based Therapies for Hematological Malignancies: An Update by the EHA SWG on Immunotherapy of Hematological Malignancies
por: Einsele, Hermann, et al.
Publicado: (2020)

Cellular immunotherapy in multiple myeloma
por: Vo, Manh-Cuong, et al.
Publicado: (2019)

NK cell-based immunotherapy for treating cancer: will it be promising?
por: Cho, Duck, et al.
Publicado: (2011)

Lactate Dehydrogenase: The Beacon of Hope?
por: Pandarathodiyil, Anitha Krishnan, et al.
Publicado: (2022)

Adoptive NK Cell Therapy - a Beacon of Hope in Multiple Myeloma Treatment
por: Vu, Son Hai, et al.
Publicado: (2023)

Cellular immunotherapy for refractory hematological malignancies
por: Reagan, John L, et al.
Publicado: (2013)

PARP inhibitors in gastric cancer: beacon of hope
por: Wang, Yali, et al.
Publicado: (2021)

Genomic Stratification of Hematological Malignancies
por: Robbe, Pauline, et al.
Publicado: (2023)

NORD. A beacon of hope for people with rare disorders
por: Putkowski, Stefanie
Publicado: (2010)

Health insurance system for hematologic diseases: what should we do?
por: Jang, Moon Ju, et al.
Publicado: (2011)

H-FABP: A beacon of hope for prediabetic heart disease
por: Ramesh, Priyamvadha, et al.
Publicado: (2020)

“A beacon of hope for relapsed multiple myeloma patients: TALVEY™”
por: Khaliq, Nawal, et al.
Publicado: (2023)

Cellular immunotherapy for hematological malignancy: recent progress and future perspectives
por: Xu, Zhengli, et al.
Publicado: (2021)

Chimeric antigen T cell receptor treatment in hematological malignancies
por: Ali, Natasha
Publicado: (2019)

The promise of immunotherapy in genitourinary malignancies
por: Zhang, Tian, et al.
Publicado: (2018)

Immunotherapy in Hematologic Malignancies: Emerging Therapies and Novel Approaches
por: Noh, Ji-Yoon, et al.
Publicado: (2020)

Hope for better environments in overcoming and curing blood cancer
por: Lee, Chul Hwan
Publicado: (2011)

The EHA Research Roadmap: Immune-based Therapies for Hematological Malignancies
por: Einsele, Hermann, et al.
Publicado: (2021)

A multifaceted approach targeting NK cells for better treatment of cancer: focus on hematological malignancies
por: Kim, Hun Sik
Publicado: (2015)

CAR-NK cell therapeutics for hematologic malignancies: hope is on the horizon
por: Xu, Kai-lin, et al.
Publicado: (2019)

Facing challenges with hope: universal immune cells for hematologic malignancies
por: Wang, Yuqing, et al.
Publicado: (2023)

The Newcomer Health Clinic in Nova Scotia: A Beacon Clinic to Support the Health Needs of the Refugee Population
por: Kohler, Graeme, et al.
Publicado: (2018)

Finding hope in two pandemics
por: Mgbako, Ofole
Publicado: (2022)

Coronavirus disease-19 and its hematological manifestations
por: Kim, Hye-Ran, et al.
Publicado: (2020)

Soil Viruses: A New Hope
por: Emerson, Joanne B.
Publicado: (2019)

Cellular immunotherapy using dendritic cells against multiple myeloma
por: Nguyen-Pham, Thanh-Nhan, et al.
Publicado: (2012)

Chimeric Antigen Receptor T-Cell Therapy: A Beacon of Hope in the Fight Against Cancer
por: Tariq, Syed Maaz, et al.
Publicado: (2018)

Immunotherapy in Thoracic Malignancies: New Treatment and New Hope
por: Melosky, Barbara
Publicado: (2022)

Molnupiravir: From Hope to Epic Fail?
por: Focosi, Daniele
Publicado: (2022)

Overview of the Side-Effects of FDA- and/or EMA-Approved Targeted Therapies for the Treatment of Hematological Malignancies
por: Constantinescu, Catalin, et al.
Publicado: (2020)

Therapeutic Advances in Immunotherapies for Hematological Malignancies
por: Nogami, Ayako, et al.
Publicado: (2022)

Editorial: Immunotherapy for hematological malignancies in children
por: Zhou, Yusi, et al.
Publicado: (2023)

Drug design for ever, from hype to hope
por: Seddon, G., et al.
Publicado: (2012)

Electroconvulsive therapy in treatment resistant schizophrenia: Old beacon of hope when nothing else works
por: Adão, C., et al.
Publicado: (2022)

Urolithiasis in Patients Suffering from Malignant Hematologic Diseases
por: Kim, Sae Woong, et al.
Publicado: (2010)

Solar Water Disinfection in Household Settings: Hype or Hope?
por: Bhutta, Zulfiqar A.
Publicado: (2009)

Bioinformatics in Malaysia: Hope, Initiative, Effort, Reality, and Challenges
por: Zeti, Azura M. H., et al.
Publicado: (2009)

When the Pandemic Will Be Over: Lots of Hope and Some Concerns
por: Azzolino, Domenico, et al.
Publicado: (2022)

From cellular to molecular mechanobiology
por: Zhu, Cheng, et al.
Publicado: (2020)

Novel cellular immunotherapies for hematological malignancies: recent updates from the 2021 ASH annual meeting
por: Wang, Ji-nuo, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_rm1n2b3crabjhloa2f614tseo4